Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has announced an update on its stock buy-back program, indicating that 700 shares were repurchased on the previous day, adding to the total of 49,490 shares bought back to date. The buy-back is an ongoing market activity, reflecting the company’s strategy to manage its share capital.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
